Home > Journals > Minerva Medica > Past Issues > Minerva Medica 2023 December;114(6) > Minerva Medica 2023 December;114(6):767-9

CURRENT ISSUE
 

JOURNAL TOOLS

Publishing options
eTOC
To subscribe
Submit an article
Recommend to your librarian
 

ARTICLE TOOLS

Publication history
Reprints
Permissions
Cite this article as
Share

 

EDITORIAL   Free accessfree

Minerva Medica 2023 December;114(6):767-9

DOI: 10.23736/S0026-4806.23.08936-X

Copyright © 2023 EDIZIONI MINERVA MEDICA

language: English

COVID-19 and endocrine disorders: a potential new trigger

Xavier CAPÓ 1, Giuseppe ANNUNZIATA 2, Manuel JIMÉNEZ-GARCIA 3, 4 , Giovanna MUSCOGIURI 5, 6, Luigi BARREA 7

1 Translational Research in Aging and Longevity (TRIAL) Group, Health Research Institute of the Balearic Islands (IdISBa), Palma, Spain; 2 Department of Experimental Medicine, Università degli Studi della Campania “Luigi Vanvitelli”, Naples, Italy; 3 Group of Neurophysiology, Department of Biology, Faculty of Science, University of the Balearic Islands, Palma, Spain; 4 Group of Neurophysiology, Behavioral Studies and Biomarkers, Health Research Institute of the Balearic Islands (IdISBa), Palma, Spain; 5 Unit of Endocrinology, Diabetology and Andrology, Department of Clinical Medicine and Surgery, University of Naples Federico II, Naples, Italy; 6 Cattedra Unesco “Educazione alla Salute e allo Sviluppo Sostenibile”, University of Naples Federico II, Naples, Italy; 7 Dipartimento di Scienze Umanistiche, Università Telematica Pegaso, Naples, Italy



top of page